Cargando…

Qualitative identification of growth hormone-releasing hormones in human plasma by means of immunoaffinity purification and LC-HRMS/MS

The use of growth hormone-releasing hormones (GHRHs) is prohibited in sports according to the regulations of the World Anti-Doping Agency (WADA). The aim of the present study was to develop a method for the simultaneous detection of four different GHRHs and respective metabolites from human plasma b...

Descripción completa

Detalles Bibliográficos
Autores principales: Knoop, Andre, Thomas, Andreas, Fichant, Eric, Delahaut, Philippe, Schänzer, Wilhelm, Thevis, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830873/
https://www.ncbi.nlm.nih.gov/pubmed/26879649
http://dx.doi.org/10.1007/s00216-016-9377-3
_version_ 1782426965141094400
author Knoop, Andre
Thomas, Andreas
Fichant, Eric
Delahaut, Philippe
Schänzer, Wilhelm
Thevis, Mario
author_facet Knoop, Andre
Thomas, Andreas
Fichant, Eric
Delahaut, Philippe
Schänzer, Wilhelm
Thevis, Mario
author_sort Knoop, Andre
collection PubMed
description The use of growth hormone-releasing hormones (GHRHs) is prohibited in sports according to the regulations of the World Anti-Doping Agency (WADA). The aim of the present study was to develop a method for the simultaneous detection of four different GHRHs and respective metabolites from human plasma by means of immunoaffinity purification and subsequent nano-ultrahigh performance liquid chromatography-high resolution/high accuracy (tandem) mass spectrometry. The target analytes included Geref (Sermorelin), CJC-1293, CJC-1295, and Egrifta (Tesamorelin) as well as two metabolites of Geref and CJC-1293, which were captured from plasma samples using a polyclonal GHRH antibody in concert with protein A/G monolithic MSIA™ D.A.R.T.’S® (Disposable Automation Research Tips) prior to separation and detection. The method was fully validated and found to be fit for purpose considering the parameters specificity, linearity, recovery (19–37 %), lower limit of detection (<50 pg/mL), imprecision (<20 %), and ion suppression/enhancement effects. The analytes’ stability and metabolism were elucidated using in vitro and in vivo approaches. EDTA blood samples were collected from rats 2, 4, and 8 h after intravenous administration of GHRH (one compound per test animal). All intact substances were detected for at least 4 h but no anticipated metabolite was confirmed in laboratory rodents’ samples; conversely, a Geref metabolite (GHRH(3-29)) was found in a human plasma sample collected after subcutaneous injection of the drug to a healthy male volunteer. The obtained results demonstrate that GHRHs are successfully detected in plasma using an immunoaffinity-mass spectrometry-based method, which can be applied to sports drug testing samples. Further studies are however required and warranted to account for potential species-related differences in metabolism and elimination of the target analytes [Figure: see text]
format Online
Article
Text
id pubmed-4830873
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-48308732016-04-22 Qualitative identification of growth hormone-releasing hormones in human plasma by means of immunoaffinity purification and LC-HRMS/MS Knoop, Andre Thomas, Andreas Fichant, Eric Delahaut, Philippe Schänzer, Wilhelm Thevis, Mario Anal Bioanal Chem Research Paper The use of growth hormone-releasing hormones (GHRHs) is prohibited in sports according to the regulations of the World Anti-Doping Agency (WADA). The aim of the present study was to develop a method for the simultaneous detection of four different GHRHs and respective metabolites from human plasma by means of immunoaffinity purification and subsequent nano-ultrahigh performance liquid chromatography-high resolution/high accuracy (tandem) mass spectrometry. The target analytes included Geref (Sermorelin), CJC-1293, CJC-1295, and Egrifta (Tesamorelin) as well as two metabolites of Geref and CJC-1293, which were captured from plasma samples using a polyclonal GHRH antibody in concert with protein A/G monolithic MSIA™ D.A.R.T.’S® (Disposable Automation Research Tips) prior to separation and detection. The method was fully validated and found to be fit for purpose considering the parameters specificity, linearity, recovery (19–37 %), lower limit of detection (<50 pg/mL), imprecision (<20 %), and ion suppression/enhancement effects. The analytes’ stability and metabolism were elucidated using in vitro and in vivo approaches. EDTA blood samples were collected from rats 2, 4, and 8 h after intravenous administration of GHRH (one compound per test animal). All intact substances were detected for at least 4 h but no anticipated metabolite was confirmed in laboratory rodents’ samples; conversely, a Geref metabolite (GHRH(3-29)) was found in a human plasma sample collected after subcutaneous injection of the drug to a healthy male volunteer. The obtained results demonstrate that GHRHs are successfully detected in plasma using an immunoaffinity-mass spectrometry-based method, which can be applied to sports drug testing samples. Further studies are however required and warranted to account for potential species-related differences in metabolism and elimination of the target analytes [Figure: see text] Springer Berlin Heidelberg 2016-02-15 2016 /pmc/articles/PMC4830873/ /pubmed/26879649 http://dx.doi.org/10.1007/s00216-016-9377-3 Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Research Paper
Knoop, Andre
Thomas, Andreas
Fichant, Eric
Delahaut, Philippe
Schänzer, Wilhelm
Thevis, Mario
Qualitative identification of growth hormone-releasing hormones in human plasma by means of immunoaffinity purification and LC-HRMS/MS
title Qualitative identification of growth hormone-releasing hormones in human plasma by means of immunoaffinity purification and LC-HRMS/MS
title_full Qualitative identification of growth hormone-releasing hormones in human plasma by means of immunoaffinity purification and LC-HRMS/MS
title_fullStr Qualitative identification of growth hormone-releasing hormones in human plasma by means of immunoaffinity purification and LC-HRMS/MS
title_full_unstemmed Qualitative identification of growth hormone-releasing hormones in human plasma by means of immunoaffinity purification and LC-HRMS/MS
title_short Qualitative identification of growth hormone-releasing hormones in human plasma by means of immunoaffinity purification and LC-HRMS/MS
title_sort qualitative identification of growth hormone-releasing hormones in human plasma by means of immunoaffinity purification and lc-hrms/ms
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830873/
https://www.ncbi.nlm.nih.gov/pubmed/26879649
http://dx.doi.org/10.1007/s00216-016-9377-3
work_keys_str_mv AT knoopandre qualitativeidentificationofgrowthhormonereleasinghormonesinhumanplasmabymeansofimmunoaffinitypurificationandlchrmsms
AT thomasandreas qualitativeidentificationofgrowthhormonereleasinghormonesinhumanplasmabymeansofimmunoaffinitypurificationandlchrmsms
AT fichanteric qualitativeidentificationofgrowthhormonereleasinghormonesinhumanplasmabymeansofimmunoaffinitypurificationandlchrmsms
AT delahautphilippe qualitativeidentificationofgrowthhormonereleasinghormonesinhumanplasmabymeansofimmunoaffinitypurificationandlchrmsms
AT schanzerwilhelm qualitativeidentificationofgrowthhormonereleasinghormonesinhumanplasmabymeansofimmunoaffinitypurificationandlchrmsms
AT thevismario qualitativeidentificationofgrowthhormonereleasinghormonesinhumanplasmabymeansofimmunoaffinitypurificationandlchrmsms